Data as of Jan 30
| -0.91 / -6.01%|
The 5 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +54.49% increase from the last price of 14.24.
The current consensus among 5 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.